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Background: In infants, sevoflurane is commonly used for induction of anesthesia, following which a muscle
relaxant is administered to facilitate tracheal intubation. When rocuronium is used as the muscle relaxant,
intubation may be performed before reaching an adequate depth of anesthesia because of its rapid onset. The
purpose of this study was to investigate the optimal sevoflurane concentration that would minimize the impact of
intubation on hemodynamics and autonomic nervous system (ANS) activity in infants.
Methods: Sixty-one infants aged 1–6 months, undergoing cleft lip repair, were enrolled. Patients were randomly
assigned to three end-tidal sevoflurane concentration (E’Sevo) groups, 3%, 4% and 5%. Anesthesia was induced with
5% sevoflurane with 100% oxygen, and rocuronium (0.6 mg/kg) was administered. The concentration of sevoflurane
was adjusted to the predetermined concentration in each group. Mechanical pressure control ventilation via a face
mask was commenced. Five minutes after E’Sevo became stable at the predetermined concentration, tracheal intubation
was performed. Immediately after tracheal intubation, ventilation was restarted at the same ventilator settings and
continued for 150 seconds. Heart rate (HR) and mean arterial pressure (MAP) were measured 5 times in the 150 seconds
after intubation. Normalized units (nu) of high frequency (HF: 0.04-0.15 Hz) and the ratio of low frequency (LF:
0.15-0.4 Hz) to HF components (LF/HF) of HR variability were calculated by MemCalc/Tonam2C™. Normalized
units of HF (HFnu) and LF/HF reflect cardiac parasympathetic and sympathetic activity, respectively.
Results: After intubation, HR increased slightly in all groups and MAP increased by 9.2% in the E’Sevo-3% group.
LF/HF increased (p < 0.01) and HFnu decreased (p < 0.01) in all groups 30 seconds after intubation. HFnu was
lower (p < 0.001) and LF/HF was higher (p = 0.007) in the E’Sevo-3% group than in E’Sevo-5% group. ANS
responses to intubation were reduced in a dose-dependent manner.
Conclusions: Sympathomimetic and parasympatholytic responses to intubation in the E’Sevo-3% group were
much greater than those in the E’Sevo-5% group. During tracheal intubation in infants, 4% or 5% sevoflurane is
appropriate for prevention of sympathetic hyperactivation and maintenance of ANS balance as compared to 3%
sevoflurane, when a muscle relaxant is co-administered.
Trial registration: The study was registered at UMIN-CTR (UMIN000009933).
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In infants, sevoflurane is commonly used for inhalational
induction of anesthesia and tracheal intubation without
muscle relaxants is well accepted [1]. However, muscle
relaxants are widely used to facilitate tracheal intubation
even in infants, because of the potential risk for move-
ment of the vocal cords, coughing and laryngospasm
[2,3]. Moreover, avoidance of muscle relaxants may in-
crease the risk of difficult tracheal intubation [4]. In
addition, there is no reason to withhold use of muscle re-
laxants, such as rocuronium, even for short duration sur-
geries, due to the ease of sugammadex-induced reversal of
relaxant activity even with short procedures [5,6]. On the
other hand, muscle relaxants can allow tracheal intubation
even under light depths of sevoflurane anesthesia [7]. In
particular, the onset time of rocuronium is so rapid that
an adequate depth of anesthesia for intubation may not
yet have been achieved.
Although several studies have assessed sevoflurane
concentration during tracheal intubation without muscle
relaxants in children, the optimal sevoflurane concentra-
tion for intubation in infants when using muscle relax-
ants is unknown. We hypothesized that laryngoscopy or
intubation under a light depth of sevoflurane anesthesia
might affect the autonomic nervous system (ANS), des-
pite excellent intubating conditions. Although muscle
relaxants facilitate tracheal intubation, their use may re-
sult in intubation under a lighter depth of sevoflurane
anesthesia, which would induce sympathetic nervous
system activation and the possibility of hemodynamic in-
stability. Therefore, appropriate anesthetic depth during
intubation is recommended to prevent ANS imbalance.
ANS activity can be evaluated by measuring heart rate
variability (HRV) indices. Spectral analysis of HRV is
widely used as a non-invasive method to assess cardiac
sympathetic and parasympathetic function [8,9]. The
purpose of this study was to investigate the appropriate
sevoflurane concentration that would minimize changes
in heart rate, heart rate variability and non-invasive
blood pressure during tracheal intubation in infants.
Methods
Study design
The study protocol was approved in November 2010 by
the Institutional Review Board and Ethics Committee of
Osaka University Dental Hospital (ref: H22-E22-1), and
was registered with UMIN-CTR (UMIN000009933).
Written informed consent was obtained from the par-
ents or guardians of all the subjects. We studied 68
cleft lip patients aged between 1 and 6 months old,
with an American Society of Anesthesiologists physical
status of 1 or 2, who were undergoing general anesthesia
for elective cheiloplasty from January 2011 to October
2013. A history of epilepsy or significant cardiopulmonary,renal or hepatic dysfunction, symptoms of an upper re-
spiratory tract infection, or predictive signs of difficult
intubation were considered criteria for exclusion from
the study.
Study protocol
Patients were randomly allocated in a single-blinded fash-
ion (patients and parents were blinded) to three groups of
end-tidal sevoflurane concentrations (E’Sevo) of 3%, 4%,
and 5%, using computer-generated randomized numbers
without any restriction before the induction of anesthesia.
All patients were made to fast for 5 hours before the in-
duction of anesthesia and did not receive premedication.
After arrival at the operating room, heart rate (HR), elec-
trocardiogram, pulse oximetry (SpO2) and noninvasive
mean arterial blood pressure (MAP) were monitored
(IntelliVue MP50, Philips, Amsterdam, the Netherlands).
Inhalation anesthesia was induced by a senior anesthetist
via a face mask, with 5% sevoflurane with 100% oxygen at
a fresh gas flow of 6 l/min using a semi-closed system, with
monitoring of end-tidal carbon dioxide (E’CO2) and E’Sevo.
After venous access was obtained, 0.6 mg/kg rocuronium
(Eslax, MSD, Tokyo, Japan) was administered. After cessa-
tion of spontaneous respiration, the concentration of sevo-
flurane was adjusted to the predetermined concentration
in each group. Mechanical pressure control ventilation via
a face mask was commenced. Since the respiratory condi-
tion might influence HRV, we applied the same ventilator
settings before and after intubation. In our preliminary
study, we determined the ventilator settings required to
achieve an E’CO2 partial pressure of 35–40 mmHg after in-
tubation as: peak pressure, 13 cm H2O; respiratory rate, 18
breaths/min; and inspiratory/expiratory ratio, 1:2.5 (Fabius
Tiro, Dräger, Lübeck, Germany). After reaching the prede-
termined value, the E’Sevo was kept constant, and the ratio
of predetermined end-tidal to inspiratory sevoflurane con-
centration was maintained at 0.90-1.00 for 5 minutes. Five
minutes after E’Sevo became stable at the predetermined
concentration, we recorded control data. The trachea was
intubated with an uncuffed, 3.5 mm ID RAE™ pediatric
orotracheal tube (Mallinckrodt, Dublin, Ireland) by a
trained anesthetist (H.H.). Tracheal intubation was per-
formed using a laryngoscope (HEINE Classic + ™ Macin-
tosh Fiber Optic Blade, size 1; HEINE, Herrsching,
Germany) and the tip of the blade was placed in the epi-
glottic vallecula. Immediately after tracheal intubation,
mechanical pressure controlled ventilation was restarted
at the same ventilator settings.
If a leak occurred at an inflation pressure less than
8 cm H2O and tidal volume was less than 3 ml/kg, the
tracheal tube was exchanged for one that was 0.5 mm
larger, and the infant was excluded from analysis. If tra-
cheal intubation was difficult and repeated laryngoscopy
was needed, data collection was discontinued.
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The fast peaks of the R-R interval (RRI) were continuously
monitored. Data were transferred to a computer loaded
with heart rate variability analysis software (MemCalc/
Tonam2C™, GMS, Tokyo, Japan). RRI data were ob-
tained at 1-ms sampling intervals and analyzed by the
maximum entropy method at high resolution with the
“MemCalc” computer program. “MemCalc” executes a
linearized version of the nonlinear least squares method
for fitting analysis in the domain, combined with the
maximum entropy method or spectral analysis method
in the frequency domain [10]. It provides reliable ana-
lysis of HRV over a minimum interval of 30 seconds
and recognizes the abnormal RRI of premature beats or
artifacts, including noise, and removes it automatically.
The power of the RRI (ms2) with LF (0.04-0.15 Hz) and
HF (0.15-0.4 Hz) bands was calculated. The total power
(TP, 0.04-0.5 Hz) was obtained by addition of LF and
HF. To confirm normal distribution, HF (proportional
power) was calculated as a percentage of TP (normal-
ized unit of HF (HFnu) = HF / TP × 100), and the LF/HF
ratio was also assessed.
Study variables
In this study, the outcome variables measured were HR,
MAP, HFnu and LF/HF. These outcome variables, ex-
cept for MAP, were measured at six time points: T0,
before intubation (5 minutes after stable state); T1,
30 seconds; T2, 60 seconds; T3, 90 seconds; T4, 120 sec-
onds; and T5, 150 seconds after tracheal intubation (at
resumption of ventilation). MAP was measured at four
time points: T0, T1, T3 and T5. The other variables
studied were demographic and perioperative variables.
Demographic variables included age and body weight,
while perioperative measurements included intubation
time, tidal volume, E’CO2 and E’Sevo. Intubation time was
defined as the time from the start of laryngoscopy to the
resumption of ventilation.
Statistical analysis
Estimated sample size was calculated based on the re-
sults of a pilot study (n = 15), where average LF/HF was
2.8 with a standard deviation (SD) of 4.5. A difference of
2.0 in the LF/HF between the E’Sevo-3% and E’Sevo-5%
groups, 30 seconds after tracheal intubation, was consid-
ered clinically relevant. With a type-2 error of 20% at a
two-sided 5% significance level, we estimated that 54 pa-
tients had to be included in this study. Finally, 68 pa-
tients were required in total when considering a dropout
rate of 20%.
Statistical analysis was performed with the SPSS Statistics
version 22.0 software package (IBM, Armonk, NY). Age,
body weight and respiratory parameters were expressed as
mean ± SD and compared by one-way analysis of variance(ANOVA). Sex was expressed as number of patients and
analyzed statistically by the Chi-square test. HR, MAP,
HFnu and LF/HF were expressed as mean ± standard er-
rors, and compared over time by one-way ANOVA for re-
peated measures, followed by the Tukey test to adjust for
multiple comparisons, where appropriate. Statistical com-
parisons between groups were assessed using one-way
ANOVA followed by the Tukey test to adjust for multiple
comparisons, where appropriate. A p-value of <0.05 was
considered significant.
Results
The flow diagram of the conduct of the study is shown
in Figure 1. Of the 75 patients who were initially assessed,
68 patients were randomly allocated to the three groups,
and 61 patients successfully completed the study without
any complications. There were no significant differences
in demographic data and respiratory parameters among
the three groups (Table 1). The E’Sevo of the three groups
was 2.91 ± 0.11% (E’Sevo-3% group), 3.88 ± 0.17% (E’Sevo-
4% group) and 4.82 ± 0.24% (E’Sevo-5% group).
Changes in each parameter before and after tracheal
intubation are indicated in Figures 2, 3, 4 and 5. HR in-
creased in all groups at T1 and T2. HR increased max-
imally at T1 by 2.9% (p < 0.001) in the E’Sevo-3% group,
by 1.9% (p < 0.001) in the E’Sevo-4% group and by 1.7%
(p < 0.001) in the E’Sevo-5% group. There were no signifi-
cant differences in HR among groups at each time point
(Figure 2). MAP increased by 9.2% (p < 0.001) at T1 and
by 4.8% (p = 0.04) at T3 in the E’Sevo-3% group. MAP de-
creased by 5.3% (p = 0.006) at T3 and by 4.9% (p = 0.011)
at T5 in the E’Sevo-5% group. MAP was higher in the
E’Sevo-3% group than in the E’Sevo-5% group at T1 (p =
0.034) and T3 (p = 0.025) (Figure 3). LF/HF increased
and HFnu decreased significantly at T1 in all groups.
HFnu was lower in the E’Sevo-3% group than in the
E’Sevo-4% group (p = 0.011) and in the E’Sevo-5% group
(p < 0.001) at T1. LF/HF was higher (p = 0.007) in the
E’Sevo-3% group than in the E’Sevo-5% group at T1. ANS
responses to intubation were reduced in a dose-dependent
manner (Figures 4 and 5).
Discussion
The major findings of this study were that (1)
hemodynamic changes due to intubation were within
10% of pre-intubation values, (2) sympathetic activation
was observed just after intubation, and (3) these re-
sponses were smaller in the E’Sevo-5% group than in the
E’Sevo-3% group.
In general, ANS activity cannot be measured directly
and continuously in humans. Assessment of heart rate
variability noninvasively provides information about sev-
eral useful indices that are associated with ANS activity.
HF (HFnu) is associated with cardiac parasympathetic
Figure 1 CONSORT flow diagram.
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sympathovagal balance or the effect of modulation of
sympathetic activity [8]. During general anesthesia, al-
though analysis of the absolute value of HF may not be
appropriate for interpreting changes in the ANS becauseTable 1 Demographic data and respiratory parameters
Variables E’Sevo-3% E’Sevo-4% E’Sevo-5% P
value(n = 21) (n = 20) (n = 20)
Age (days) 95.2 ± 19.2 90.0 ± 13.4 96.7 ± 14.9 0.382
Sex (male/female) 14/7 10/10 12/8 0.552
Body weight (kg) 5.9 ± 0.9 5.8 ± 0.9 6.2 ± 0.7 0.303
Intubation time (sec) 29.8 ± 10.4 30.9 ± 9.5 28.0 ± 7.4 0.598
Tidal volume (ml)
Before intubation (T0) 79.1 ± 16.9 79.1 ± 21.1 80.4 ± 19.4 0.971
After intubation (T1) 53.1 ± 15.5 46.9 ± 17.2 51.5 ± 16.1 0.456
E’CO2 (mmHg)
Before intubation (T0) 27.5 ± 4.4 26.4 ± 3.1 28.8 ± 3.9 0.147
After intubation (T1) 35.9 ± 4.3 37.1 ± 6.1 37.3 ± 4.3 0.624
Demographic data and respiratory parameters in each group. Data are
expressed as mean ± SD or number of patients.
E’CO2, end-tidal carbon dioxide.of overall depression of the TP, the relative value (HFnu)
may still be useful for interpretation of ANS activity
when an overall decrease in all components occurs [11].
Therefore, we used the relative value in our study.
In the present study, we estimated that increase in
sympathetic activity and decrease in parasympathetic ac-
tivity occurred 30 seconds after intubation, as indicated
by the increase in LF/HF and decrease in HFnu, respect-
ively. The increase in LF/HF and decrease in HFnu were
smaller in the E’Sevo-5% group than in the E’Sevo-3%
group. Therefore, we estimated that the ANS responses
to intubation were reduced by sevoflurane in a dose-
dependent manner.
It is important to consider the respiratory conditions
that have an impact on HRV [12]. As long as respiratory
rate remains unchanged, changes in end-tidal CO2 or
tidal volume have little impact on HRV in anesthetized
patients [13]. However, because apnea is inevitable dur-
ing laryngoscopy and tracheal intubation, it is meaning-
less to compare the results of HRV obtained during
these manipulations with those during mechanical venti-
lation [14]. Therefore, in this study, in order to avoid the
influence of apnea, HRV data from the start of laryngoscopy
Figure 2 Time course of heart rate. Time course of heart rate (HR)
before and after intubation in E’Sevo-3% (circle points and solid line),
E’Sevo-4% (square points and broken line) and E’Sevo-5% (triangle
points and dotted line) groups. Data are presented as mean (standard
error). T0, before intubation; T1, 30 seconds; T2, 60 seconds; T3,
90 seconds; T4, 120 seconds; and T5, 150 seconds after tracheal
intubation. *, p < 0.05 vs. T0; **, p < 0.01 vs. T0; †, p < 0.05 E’Sevo-
3% vs. E’Sevo-5%.
Figure 4 Time course of normalized units of HF. Time course of
normalized units of HF (HFnu) before and after intubation in E’Sevo-
3% (circle points and solid line), E’Sevo-4% (square points and broken
line) and E’Sevo-5% (triangle points and dotted line) groups. Data are
presented as mean (standard error). T0, before intubation; T1, 30 seconds;
T2, 60 seconds; T3, 90 seconds; T4, 120 seconds; and T5, 150 seconds
after tracheal intubation. **, p < 0.01 vs. T0; †, p < 0.05 E’Sevo-3%
vs. E’Sevo-4%; ††, p < 0.01 E’Sevo-3% vs. E’Sevo-5%.
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cluded, since HRV data are calculated from the RRIs for
30 seconds in the MemCalc™ system.
In the present study, we investigated the appropriate
depth of sevoflurane anesthesia for intubation in infants.
Although minimum alveolar concentration (MAC) [15]
is usually determined by the up-and-down method, we
could not use this method because HRV is usually
assessed using relative changes, and the cutoff value of
ANS activity is unclear. Therefore, we compared the
hemodynamic and ANS changes induced by intubationFigure 3 Time course of mean arterial pressure. Time course of
mean arterial pressure (MAP) before and after intubation in E’Sevo-3%
(circle points and solid line), E’Sevo-4% (square points and broken
line) and E’Sevo-5% (triangle points and dotted line) groups. Data are
presented as mean (standard error). T0, before intubation; T1, 30 seconds;
T2, 60 seconds; T3, 90 seconds; T4, 120 seconds; and T5, 150 seconds
after tracheal intubation. **, p < 0.01 vs. T0; †, p < 0.05 E’Sevo-3% vs. E’Sevo-
4%; ††, p < 0.01 E’Sevo-3% vs. E’Sevo-5%.at different sevoflurane concentrations. The concentration
of sevoflurane was determined with reference to the value
of MAC for tracheal intubation (MAC-TI) or blocking ad-
renergic responses (MAC-BAR) in infants.
The MAC in pediatric patients changes with age
[16-19]. The MAC of sevoflurane is highest in younger
patients: 3.3% for neonates, 3.2% for infants 1 to
6 months old and 2.5% for children older than 6 months
[16,17]. MAC-TI is assessed based on the intubating
conditions, such as coughing, movements of the vocal
cords or limbs, and whether tracheal intubation is smoothFigure 5 Time course of low frequency to high frequency components.
Time course of low frequency to high frequency components (LF/HF)
before and after intubation in E’Sevo-3% (circle points and solid
line), E’Sevo-4% (square points and broken line) and E’Sevo-5%
(triangle points and dotted line) groups. Data are presented as
mean (standard error). T0, before intubation; T1, 30 seconds; T2,
60 seconds; T3, 90 seconds; T4, 120 seconds; and T5, 150 seconds
after tracheal intubation. **, p < 0.01 vs. T0; ††, p < 0.01 E’Sevo-3%
vs. E’Sevo-5%.
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MAC-TI of sevoflurane at different ages was 2.69% (age,
1–9 years), 3.10% (age, 2–8 years) and 2.49% (age, 2–6
years). However, there was no available data for infants
less than 1 year of age. The ratio of MAC-TI/MAC is re-
ported to be 1.33 in children (age, 1–9 years) [18]. If this
ratio is applied to our patients (aged 1–6 months), the
MAC-TI is calculated as 4.26%. Clinically, when intubat-
ing with sevoflurane alone, a higher concentration than
MAC-TI is required to accomplish successful intubation.
Hence, anesthetists need to refer to the 95% effective dose
of MAC-TI (MAC-TIED95) rather than MAC-TI, to
achieve effective reduction of the stress associated with in-
tubation in almost all patients. Although the MAC-TIED95
in children (age, 1–7 years) was reported as 3.54%, [16] its
value in infants is unknown. In the present study, consid-
ering MAC-TI and MAC-BAR, the ANS and hemodynamic
responses to intubation were explored at 3%, 4%, and 5%
sevoflurane anesthesia.
In clinical settings, muscle relaxants are commonly
used to facilitate tracheal intubation even in pediatric
patients [1]. With the use of muscle relaxants, tracheal
intubation can be performed even under light or moderate
anesthesia [7,23]. However, when using muscle relaxants,
it is difficult to evaluate the optimal depth of anesthesia
for intubation because muscle relaxants can improve in-
tubation conditions regardless of the depth of anesthesia.
Therefore, other measurements are required to determine
the optimal depth of anesthesia.
MAC-BAR is a clinically important index that is assessed
by the increase in HR or blood pressure. The cut-off value
for determination of MAC-BAR is usually an increase in HR
or MBP by 10% [24] to 15% [25-27]. In the present study,
the changes in HR and MAP were within 10% after intub-
ation, which is considered to be acceptable. On the other
hand, ANS responses are extremely sensitive to noxious
stimulation even if hemodynamic changes are small. Sympa-
thetic activation due to intubation was observed in all
groups and was larger in the E’Sevo-3% than in the E’Sevo-5%
group. Although MAP remained unchanged in the E’Sevo-
4% group, 5% sevoflurane reduced it. These results suggest
that 5% sevoflurane might be too high for intubation. There-
fore, 4% sevoflurane, which would minimize the changes in
ANS activity without producing side effects, such as
hemodynamic depression, might be adequate for intubation.
In our study, although we kept the sevoflurane concentra-
tion constant until 150 seconds after tracheal intubation to
conduct the analyses, inhalation of 5% sevoflurane until tra-
cheal intubation, with a decrease in the sevoflurane dose to
a level required for maintenance of anesthesia immediately
after tracheal intubation, might also be acceptable in daily
clinical practice.
Measurement of plasma catecholamine concentration
is one of the most common methods for assessing ANSactivity. Although the catecholamine response to tra-
cheal intubation is similar to heart rate and blood pres-
sure responses in children, the magnitude of the changes
seems to be different [28]. Evaluation of the ANS re-
sponse to intubation by catecholamine measurements is
difficult because it is not sensitive enough and requires
repeated blood sampling in a short time interval. There-
fore, we used HRV to assess the ANS response in this
study, because HRV data is available non-invasively
every 30 seconds by using the MemCalc system.
In our study, only sevoflurane was used as the anesthetic
agent during induction of anesthesia and tracheal intub-
ation. This method makes it possible to investigate the
effect of sevoflurane itself. However, sevoflurane with fen-
tanyl [21], remifentanil or propofol [29] can also be used
for tracheal intubation in children. Further study on the
effects of these adjuvant drugs combined with sevoflurane
on heart rate variability is needed.
There are some limitations to the present study. First,
the conventional method of determining MAC-TI re-
quires a constant end-tidal concentration of volatile an-
esthetics to be maintained for at least 15 minutes, to
establish equilibration between cerebral, arterial blood
and alveolar gas tensions before tracheal intubation [18].
However, since administration of inhalational anesthetics
for 15 minutes in order to achieve the steady state is not
followed in routine clinical practice, we did not wait for
15 minutes before obtaining measurements in our pa-
tients as it would mean an excessive exposure to anes-
thetics purely for research purposes, which we believe is
unethical. Although Inomata et al. studied MAC-TI
without achievement of the steady state (rapid method)
[22], we considered 5 minutes adequate for achieving
the steady state, in accordance with their other recent
study on MAC-TI [21]. Second, in this study, pre-
intubation E’CO2 was smaller than post-intubation E’CO2.
Although the ventilator settings were equal before and
after intubation, the difference in E’CO2 was considered
to be acceptable because of the changes in dead space
before and after tracheal intubation. Similar E’CO2 data
were shown in a previous study [30]. Third, the optimal
anesthetic depth during tracheal intubation is still an
issue. Tracheal intubation should be performed principally
for the benefit of the patient rather than the satisfaction of
the anesthesiologist [6]. The target anesthetic depth is
different for each anesthesiologist and the ideal target,
whether prevention of the ANS response, hemodynamic re-
sponse, body movement or patients’ memory, is still con-
troversial. Further studies and discussion about optimal
anesthetic depth during tracheal intubation are still needed.
Conclusion
During tracheal intubation in infants, 4 or 5% of sevo-
flurane is appropriate for the prevention of sympathetic
Hanamoto et al. BMC Anesthesiology  (2015) 15:64 Page 7 of 7hyperactivation and maintenance of ANS balance as
compared to 3% sevoflurane, when a muscle relaxant is
co-administered.
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